mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
6e-06 |
mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
7e-06 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
7e-06 |
mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
0.25 |
1e-05 |
mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
1e-05 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
1e-05 |
mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
1e-05 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
mRNA |
PHA-793887 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
2e-05 |